Up-regulation of the RhoA/Rho-kinase signaling pathway in corpus cavernosum from endothelial nitric-oxide synthase (NOS), but not neuronal NOS, null mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 1, 2010, Pages 184-192

  Priviero, Fernanda B M ^a   Jin, Li Ming ^b   Ying, Zhekang ^a   Teixeira, Cleber E ^a   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 1 [(4 METHYL 5 ISOQUINOLINYL)SULFONYL]HOMOPIPERAZINE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; H 1152; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SODIUM NITRIC OXIDE; THREONINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS CAVERNOSUM; ELECTROSTIMULATION; ENDOTHELIUM CELL; EVOKED RESPONSE; KNOCKOUT MOUSE; LEUKEMIA; MALE; MOUSE; MOUSE STRAIN; MUSCLE CONTRACTION; MUSCLE FIBER CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; MYOGRAPHY; NONHUMAN; PDZ DOMAIN; PENIS ERECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; AMIDES; ANIMALS; CYCLIC GMP; ENDOTHELIUM, VASCULAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; PENIS; PYRIDINES; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; UP-REGULATION;

EID: 77949709958     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.160606     Document Type: Article

References (32)

1. Andersson KE (2001) Pharmacology of penile erection. Pharmacol Rev 53:417-450.
2. Bivalacqua TJ, Champion HC, Usta MF, Cellek S, Chitaley K, Webb RC, Lewis RL, Mills TM, Hellstrom WJ, and Kadowitz PJ (2004) RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: a mechanism for diabetes-associated erectile dysfunction. Proc Natl Acad Sci U S A 101:9121-9126.
3. Cellek S (2000) Nitrergic-noradrenergic interaction in penile erection: a new insight into erectile dysfunction. Drugs Today 36:135-146.
4. Chang S, Hypolite JA, Changolkar A, Wein AJ, Chacko S, and DiSanto ME (2003) Increased contractility of diabetic rabbit corpora smooth muscle in response to endothelin is mediated via Rho-kinase beta. Int J Impot Res 15:53-62.
5. Chang S, Hypolite JA, Zderic SA, Wein AJ, Chacko S, and Disanto ME (2005) Increased corpus cavernosum smooth muscle tone associated with partial bladder outlet obstruction is mediated via Rho-kinase. Am J Physiol Regul Integr Comp Physiol 289:R1124-R1130.
6. Chitaley K and Webb RC (2002) Nitric oxide induces dilation of rat aorta via inhibition of rho-kinase signaling. Hypertension 39:438-442.
7. Chitaley K, Wingard CJ, Clinton Webb R, Branam H, Stopper VS, Lewis RW, and Mills TM (2001) Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 7:119-122.
8. Dean RC and Lue TF (2005) Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin North Am 32:379-395.
9. Do e Z, Fukumoto Y, Takaki A, Tawara S, Ohashi J, Nakano M, Tada T, Saji K, Sugimura K, Fujita H, et al. (2009) Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension. Circ J 73:1731-1739.
10. Ellerbroek SM, Wennerberg K, and Burridge K (2003) Serine phosphorylation negatively regulates RhoA in vivo. J Biol Chem 278:19023-19031.
11. Etter EF, Eto M, Wardle RL, Brautigan DL, and Murphy RA (2001) Activation of myosin light chain phosphatase in intact arterial smooth muscle during nitric oxide-induced relaxation. J Biol Chem 276:34681-34685.
12. Govers R and Rabelink TJ (2001) Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 280:F193-F206.
13. Guilluy C, Eddahibi S, Agard C, Guignabert C, Izikki M, Tu L, Savale L, Humbert M, Fadel E, Adnot S, et al. (2009) RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling. Am J Respir Crit Care Med 179:1151-1158.
14. Guven A, Onal B, Kalorin C, Whitbeck C, Chichester P, Kogan B, Levin R, and Mannikarottu A (2007) Long term partial bladder outlet obstruction induced contractile dysfunction in male rabbits: a role for Rho-kinase. Neurourol Urodyn 26:1043-1049.
15. Hilgers RH, Todd J Jr, and Webb RC (2007) Increased PDZ-RhoGEF/RhoA/Rho kinase signaling in small mesenteric arteries of angiotensin II-induced hypertensive rats. J Hypertens 25:1687-1697.
16. Jin L and Burnett AL (2006) RhoA/Rho-kinase in erectile tissue: mechanisms of disease and therapeutic insights. Clin Sci 110:153-165.
17. Jin L, Liu T, Lagoda GA, Champion HC, Bivalacqua TJ, and Burnett AL (2006) Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for ageassociated erectile dysfunction. FASEB J 20:536-538.
18. Lin CS, Xin ZC, Wang Z, Lin G, and Lue TF (2008) Molecular Yin and Yang of erectile function and dysfunction. Asian J Androl 10:433-440.
19. Mills TM, Chitaley K, Wingard CJ, Lewis RW, and Webb RC (2001) Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J Appl Physiol 91:1269-1273.
20. Mills TM, Lewis RW, Wingard CJ, Chitaley K, and Webb RC (2002) Inhibition of tonic contraction-a novel way to approach erectile dysfunction. J Androl 23: S5-S9.
21. Noda K, Oka M, Ma FH, Kitazawa S, Ukai Y, and Toda N (2001) Release of endothelial nitric oxide in coronary arteries by celiprolol, a beta(1)-adrenoceptor antagonist: possible clinical relevance. Eur J Pharmacol 415:209-216.
22. Priviero FB, Leite R, Webb RC, and Teixeira CE (2007) Neurophysiological basis of penile erection. Acta Pharmacol Sin 28:751-755.
23. Rees RW, Ralph DJ, Royle M, Moncada S, and Cellek S (2001) Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br J Pharmacol 133:455-458.
24. Rees RW, Ziessen T, Ralph DJ, Kell P, Moncada S, and Cellek S (2002) Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Int J Impot Res 14:1-7.
25. Sawada N, Itoh H, Yamashita J, Doi K, Inoue M, Masatsugu K, Fukunaga Y, Sakaguchi S, Sone M, Yamahara K, et al. (2001) cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 280:798-805.
26. Teixeira CE, Jin L, Ying Z, Palmer T, Priviero FB, and Webb RC (2005a) Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery. Clin Exp Pharmacol Physiol 32:817-824.
27. Teixeira CE, Priviero FB, and Webb RC (2007) Effects of 5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl] pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity/ expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice. J Pharmacol Exp Ther 322:1093-1102.
28. Teixeira CE, Ying Z, and Webb RC (2005b) Proerectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl] homopiperazine (H-1152) in the rat penis. J Pharmacol Exp Ther 315:155-162.
29. 2+ sensitization in erectile function. J Biol Chem 277:30614-30621.
30. Webb RC (2003) Smooth muscle contraction and relaxation. Adv Physiol Educ 27:201-206.
31. Williams J, Bogwu J, and Oyekan A (2006) The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice. J Hypertens 24:1429-1436.
32. Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, and Liao JK (2004) Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24:1842-1847.